Bahrain is the second country in the world, after the United Kingdom, to announce its approval of the use of the Pfizer-Biontech vaccine against the novel coronavirus, according to the CEO of the National Authority for Regulating Professions and Health Services, Maryam Al-Jalahma, on Saturday.
Jalahma said in a statement that Bahrain has approved the emergency use of the Pfizer-Biontec anti-COVID-19 vaccine, becoming the second country to give the green light for adoption after the United Kingdom.
Manama has yet to specify the schedule for the planned vaccination program.
In a statement published by the state news agency, Jalahma, stated that "intensive meetings were held to study the documents submitted by the company, which included the quality of manufacturing and the results of safety analysis during the past two months.”
“The authority also held extensive meetings with the company’s team in The United States of America and its representatives to answer all inquiries submitted by the authority,” she added.
On her part, Lindsay Ditchie, head of the Pfizer Gulf Group, said, "Today's emergency use license in the Kingdom of Bahrain represents another historic moment in the battle against the coronavirus.”
“This license is a goal we have been working to achieve since we first announced that science will win," she stressed.
Moreover, Manama, which recorded more than 87,000 infections, including 341 deaths, had also approved in November the use of the Chinese company Sinopharm’s vaccine.
Follow the latest news on Google News
